Metabolic Stress Rewires the Golgi, Sphingolipids and Lipid Droplets in Failing Beta Cells

Pancreatic beta cells are among the most metabolically burdened cells in the human body, tasked with manufacturing, folding and secreting insulin on demand for decades without pause. When blood sugar and fatty acid levels climb chronically, as they do in obesity and type 2 diabetes, these cells begin to falter, but the earliest molecular events that tip them toward dysfunction remain only partially mapped. A new study published in Molecular Biology Reports by Neslihan Başçıl Tütüncü and colleagues at Başkent University in Ankara now adds an unexpected player to that map: the Golgi apparatus. The researchers show that in insulin-producing INS-1E beta cells, metabolic stress does not merely burden the endoplasmic reticulum, the long-standing focus of diabetes research, but simultaneously remodels a coordinated network spanning the Golgi, sphingolipid metabolism and lipid droplet biology, producing what the authors describe as an integrated molecular signature of early beta-cell vulnerability.

The experimental design was deliberately simple yet revealing. INS-1E cells, a well-characterized rat insulinoma line widely used as a model of pancreatic beta-cell biology, were exposed for 24 hours to one of three stress conditions: a high concentration of glucose at 33 millimolar, the saturated fatty acid palmitic acid at 0.5 millimolar, or both together, a combination meant to mimic the glucolipotoxic environment of untreated type 2 diabetes. These three conditions allowed the team to disentangle the effects of excess sugar alone, excess fat alone, and the combined burden that patients with metabolic syndrome experience continuously. After the exposure window, the researchers measured cellular metabolic activity with an MTT assay and probed the abundance of a panel of proteins by Western blotting, while fluorescence microscopy with NBD-labeled ceramide tracked how the cells handled this pivotal sphingolipid.

The choice to focus on the Golgi apparatus is what sets this work apart. For more than two decades, endoplasmic reticulum stress has dominated the literature on beta-cell failure, with the unfolded protein response well documented as a driver of dysfunction and death under glucotoxic and lipotoxic conditions. The Golgi, which sits downstream of the ER in the secretory pathway and processes the proinsulin and granule proteins that beta cells ship in enormous quantities, has received far less attention. Yet the Golgi runs its own stress response programs, including pathways built around the transcription factor CREB3 and the small GTP-binding protein ARF4, which coordinate membrane traffic and secretory capacity when the organelle is overloaded. Disruption of Golgi homeostasis has recently been implicated computationally as a signature of beta-cell stress in diabetes, making the proteins the Turkish team chose to measure biologically meaningful sentinels rather than arbitrary markers.

What the team found was a pattern of coordinated change rather than isolated perturbations. Metabolic stress altered the abundance of Golgi stress-associated proteins, including CREB3 and ARF4, indicating that the organelle’s own alarm systems were engaged by the nutrient overload. At the same time, expression of SMPD1 and SMPD2, the genes encoding acid and neutral sphingomyelinases, increased across the stressed conditions. These enzymes cleave sphingomyelin to generate ceramide, a lipid with well-documented roles in apoptosis, insulin signaling interference and ion channel dysfunction in beta cells. The rise in sphingomyelinase expression was matched at the cellular level: NBD-ceramide fluorescence increased, consistent with altered ceramide handling and trafficking within the stressed cells. Together, these observations suggest that metabolic stress pushes beta cells toward a sphingolipid-rich, pro-apoptotic lipid environment.

The ceramide connection carries particular weight because of what earlier studies have established about this lipid class in diabetes. Ceramides generated de novo or through sphingomyelin hydrolysis have been shown to promote beta-cell apoptosis under glucolipotoxic conditions, and specific ceramide species with defined acyl chain lengths have been linked to lipotoxicity-induced cell death in INS-1 cells. More recent work has demonstrated that sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis, and that glucolipotoxicity can impair the normal flow of ceramide from the endoplasmic reticulum to the Golgi apparatus, precisely the trafficking route that depends on Golgi function. The new findings slot neatly into this picture: if the Golgi itself is stressed and ceramide handling is altered, the cell faces a double hit in which both the lipid signal and the organelle responsible for processing secretory cargo are compromised simultaneously.

Equally striking was the behavior of the lipid droplet machinery. Perilipin-3, a coat protein that stabilizes lipid droplets and regulates access of lipases to their stored triglyceride cargo, increased under metabolic stress, but ATGL, the rate-limiting triglyceride lipase that mobilizes those stores, did not change correspondingly. The authors interpret this imbalance as a shift toward lipid sequestration: the cell appears to be banking fat into droplets rather than burning it. This response has a well-documented protective logic. Studies going back to the early 2000s showed that triglyceride accumulation in beta cells can buffer against fatty acid toxicity, and perilipin overexpression in INS-1 cells protects against lipotoxicity. Storing excess palmitate in inert droplets keeps it from entering ceramide synthesis pathways or damaging membranes. But the strategy may be a double-edged sword, because droplet dynamics are themselves disrupted in type 2 diabetes, and a sequestration-dominant state without matched lipolytic capacity could eventually leave droplets unable to release fatty acids when the cell needs them, or could reflect a cell already losing metabolic flexibility.

The functional consequences of the different stress regimes were not uniform, and this selectivity is one of the study’s most informative results. High glucose alone largely preserved metabolic activity over the 24-hour window, even as it perturbed Golgi and lipid-handling markers. Palmitic acid, by contrast, and the combined glucose-palmitate treatment, reduced both metabolic activity and the expression of PC1/3, the prohormone convertase responsible for cleaving proinsulin into mature, active insulin within the secretory granules. A drop in PC1/3 is not a subtle biochemical footnote; it strikes directly at the cell’s core product, impairing the processing pipeline that converts inactive precursor into the hormone that regulates blood glucose throughout the body. Notably, Syntaxin 6 and Syntaxin 12/13, SNARE proteins involved in intracellular trafficking of granule components, remained unchanged, suggesting that the early stress signature is selective rather than a wholesale collapse of the trafficking machinery.

Taken together, the molecular changes sketch a coherent early-warning profile. Before overt cell death, stressed beta cells show Golgi stress protein remodeling, elevated sphingomyelinase expression and ceramide accumulation, a perilipin-3-driven shift toward lipid storage, and declining proinsulin processing capacity, with the most severe combination appearing under glucolipotoxic conditions. The authors are careful to frame these as correlated molecular alterations rather than proven causal mechanisms, and they state explicitly that functional and lipidomic studies are now needed to determine how these changes contribute to beta-cell dysfunction. That caveat matters: Western blotting of a handful of proteins in one cell line cannot capture the full lipidome or the dynamic flux of ceramide species, and INS-1E cells, while a valuable model, are transformed cells whose stress responses may not perfectly mirror primary human beta cells.

Even with those limitations, the study’s integrative framing points toward clinically relevant directions. Ceramides are increasingly recognized as biomarkers of lipotoxicity in obesity, diabetes and cardiovascular disease, and therapeutic strategies targeting ceramide synthesis are under active investigation for early cardiometabolic disease. If Golgi stress and sphingolipid remodeling indeed constitute an early signature of beta-cell vulnerability, they could offer detection points well before irreversible cell loss, and lipid droplet biology, long dismissed as inert storage, continues to emerge as a manipulable node of stress management in metabolically challenged cells. For a disease that develops over years of silent beta-cell decline, identifying the earliest coordinated molecular tremors, in this case across an organelle axis that spans the Golgi, the sphingolipid pool and the lipid droplet, may prove to be exactly the kind of head start that prevention strategies have been looking for.

Subject of Research: Golgi stress, sphingolipid metabolism and lipid droplet remodeling in metabolically stressed pancreatic beta cells

Article Title: Metabolic stress remodels the Golgi-sphingolipid-lipid droplet axis in INS-1E β-cells: an integrated molecular signature of early β-cell vulnerability

Article References: Başçıl Tütüncü, N., Baysan Çebi, H. P., Yalçın, Y., Verdi, H., & Ataç, F. B. (2026). Metabolic stress remodels the Golgi-sphingolipid-lipid droplet axis in INS-1E β-cells: an integrated molecular signature of early β-cell vulnerability. Molecular Biology Reports, 53(1), Article 1697. https://doi.org/10.1007/s11033-026-12857-w

Image Credits: AI Generated

DOI: 10.1007/s11033-026-12857-w

Keywords: Golgi stress, sphingolipid metabolism, ceramide, lipid droplets, perilipin-3, beta-cell dysfunction, glucolipotoxicity, INS-1E cells, type 2 diabetes, PC1/3, palmitic acid, insulin processing